Meyka AI API is live for developers.Start building.
Advertisement
Lannett Company, Inc.

Lannett Company, Inc. (LCI) Stock Overview

Explore Lannett Company, Inc.’s financial performance, market position, analyst ratings, and future outlook.

LCINYSE
HealthcareDrug Manufacturers - Specialty & Generic
$0.69
$0.03(3.86%)
U.S. Market opens in 57h 34m
Advertisement

Lannett Company, Inc. (LCI)

Meyka AI Score

Z

Key Financials

Market Cap7.4M
P/E Ratio-0.03
EPS (TTM)$-19.14
ROE1.66%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

LCI Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Lannett Company, Inc. (LCI) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.03 and a market capitalization of 7.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
-72.36%
6-Month Change
-71.20%
Year-to-Date (YTD) Change
-67.79%
1-Year Change
-67.48%
3-Year Change
-97.62%
5-Year Change
-98.99%
All-Time (Max) Change
-93.57%

Contact Information

215 333 9000
1150 Northbrook Drive, Trevose, PA, 19053

Company Facts

5,640 Employees
IPO DateDec 13, 2013
CountryUS

Frequently Asked Questions